Dificid (fidaxomicin) a treatment for CDAD

The most recent antibiotic, Dificid (fidaxomicin) is the first medication approved by FDA to treat CDAD in twenty five years with superiority in sustained clinical response

DIFICID® is a macrolide antibacterial drug indicated in adults ≥18 years of age for treatment of Clostridium difficile-associated diarrhea.

For complete information available regarding this medication please visit their web-site: